We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
Information for healthcare professionals on Guillain-Barré Syndrome (GBS) following COVID-19 vaccination.
Information for parents of eligible at-risk children aged 6 months to 11 years on COVID-19 vaccination.
Pre COVID-19 vaccination checklist for parents of children aged 12 to 15 years
Information for eligible children and young people aged 12 to 17 years on COVID-19 vaccination.
Leaflet for people eligible for COVID-19 vaccination who have had their first dose of AstraZeneca vaccine and have concerns about having the second dose.…
Information on the third and booster doses for people with a weakened immune system.
Information on the spring 2024 campaign for eligible individuals.
Information resources for prisons, immigration removal centres and other secure settings.
Knowledge and skills competence assessment tool.
Managing acute respiratory illness (ARI) in prisons and other prescribed places of detention (PPDs) and in the Children and Young People Secure Estate (CYPSE).
Guidance on the use of personal protective equipment (PPE) for aerosol generating procedures (AGPs).
This report provides information on worklessness and support available to local authorities to mitigate worklessness locally.
Explains the process for both primary and confirmatory testing of human samples for MERS-CoV testing, when MERS is being considered as a diagnosis.
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
Guidance on the use of personal protective equipment (PPE) for non-aerosol generating procedures (APGs).
Notifications of infectious diseases (NOIDs) and reportable causative organisms: legal duties of laboratories and medical practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).